Market Cap (In CNY)
17.27 Billion
Revenue (In CNY)
2.5 Billion
Net Income (In CNY)
184.61 Million
Avg. Volume
10.95 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 12.74-31.08
- PE
- -51.59
- EPS
- -0.75
- Beta Value
- 0.574
- ISIN
- CNE1000035J7
- CUSIP
- -
- CIK
- -
- Shares
- 446576895.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Hanxiong Li
- Employee Count
- -
- Website
- https://www.gdyph.com
- Ipo Date
- 2017-11-16
- Details
- ApicHope Pharmaceutical Co., Ltd, together with its subsidiaries, engages in the research and development, production, and sale of pharmaceutical products. It offers anti-infection, pediatric, cardiovascular, genitourinary, respiratory, liver and digestion, and dermatological products, as well as anti-inflammatory and analgesic products. The company was formerly known as Yipinhong Pharmaceutical Co.,Ltd and changed its name to ApicHope Pharmaceutical Co., Ltd in December 2021. ApicHope Pharmaceutical Co., Ltd was founded in 2002 and is based in Guangzhou, China.
More Stocks
-
CFRESH
-
FARYFFAR Limited
FARYF
-
AS
-
ATKRAtkore Inc.
ATKR
-
0251
-
EPE
-
BCTCF
-
MODRNSH